Clinical Trials Directory

Trials / Unknown

UnknownNCT01078792

Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

Status
Unknown
Phase
—
Study type
Observational
Enrollment
—
Sponsor
Hillel Yaffe Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine the possible association of prothrombin fragments 1+2 elevation with incidents of pulmonary embolism in patients with COPD exacerbation.

Conditions

Interventions

TypeNameDescription
OTHERCT pulmonary angio, blood tests

Timeline

First posted
2010-03-02
Last updated
2010-03-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01078792. Inclusion in this directory is not an endorsement.

Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence (NCT01078792) · Clinical Trials Directory